Page 2 - Biosimilar Type News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Biosimilar type. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Biosimilar Type Today - Breaking & Trending Today

Biosimilars coming into their own in China, despite concerns

The timing is ripe for a robust biosimilar market in China, given the rapid increase of novel biologics approved to treat cancer and inflammatory diseases in the country over the past decade and the looming patent cliffs for several established biologics. As of December, the NMPA had approved more than 20 biosimilars that were developed in China. Most of those referenced just two biologics – Roche AG’s cancer drug Avastin (bevacizumab) and Abbvie Inc.’s immunology drug Humira (adalimumab). In 2022, the oncology and immunology biosimilar market in China garnered sales of about $2 billion, according to Clarivate estimates. To reach their full potential in China though, biosimilars must win over prescribers and patients. ....

Abbvie Inc , Roche Ag , Abbvie Inc , Pfizer Inc , Henlius Biotech Inc , Asia Pacific ,

Global Biobetters Market Analysis to 2034 by Drug Class,

Dublin, April 09, 2024 (GLOBE NEWSWIRE) The ....

United States , South Korea , United Kingdom , South Africa , Eli Lilly , Asia Pacific , Samsung Bioepis , Alector Biosciences , Teva Pharmaceuticals , Exhaustive Company Profiles Of The Top , Bristol Myers Squibb , Roche Group , Route Of Administration , Merck Co , Biobetters Market , Drug Class , Disease Indication , Distribution Channel , Elly Lilly Japan , Company Profiles , Major Market , Market Value , Research And Markets , Iosimilars And Biosuperiors ,

9 Biosimilars for Intravitreal nAMD, DME Treatment

A number of biosimilar options to treat the common retina diseases are in development globally. Here’s a highlight of 9 with supporting late-stage data. ....

South Korea , P Biocon Biologics , Aflibercept Eylea Biosimilars , Chong Kun Dang , Ranibizumab Lucentis Biosimilars , Samsung Bioepis , Momenta Pharmaceuticals , Biocon Biologics , Age Related Macular Degeneration , Diabetic Macular Edema , Anti Vegf ,

US Pharmaceutical Market Review 2020-2023 and Forecast

Dublin, March 27, 2024 (GLOBE NEWSWIRE) The ....

United States , Eli Lilly , Biologics Biosimilars , Abbvie Inc , National Health Service , Vertex Pharmaceuticals Inc , Amgen Inc , Gilead Sciences Inc , Bristol Myers Squibb Co , Abbott Laboratories , Takeda Pharmaceutical Co , Cardinal Health , Bayer Ag , Merck Co , Zoetis Inc , Moderna Inc , Iktos Pharmaceuticals , Regeneron Pharmaceuticals Inc , Pfizer Inc , Market Size , Regional Share , Growth Opportunity Analysis Report Coverage , Small Molecules , Compound Annual Growth Rate , United Kingdom Based , Insilico Medicine ,